Literature DB >> 28436210

Stereotactic body radiotherapy for pediatric hepatocellular carcinoma with central biliary obstruction.

Susan M Hiniker1,2, Arun Rangaswami3, Matthew P Lungren4, Avnesh S Thakor4, Waldo Concepcion5, Kathleen E Balazy1, Nataliya Kovalchuk1, Sarah S Donaldson1,2.   

Abstract

Here, we present the case of a pediatric patient with newly diagnosed hepatocellular carcinoma causing central biliary obstruction and persistently elevated bilirubin of 3.0-4.3 mg/dl despite placement of bilateral internal-external biliary drains. The tumor was not resectable, and the patient was not a candidate for liver transplant due to nodal disease, for chemotherapy due to hyperbilirubinemia, or for local therapies aside from stereotactic body radiotherapy (SBRT). In this report, we discuss the successful use of SBRT in the management of this patient, and its role in allowing the patient to become a candidate for additional therapies.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  HCC; SBRT; hepatocellular carcinoma; stereotactic body radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 28436210     DOI: 10.1002/pbc.26330

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.

Authors:  Christopher L Tinkle; Charu Singh; Shane Lloyd; Yian Guo; Yimei Li; Alberto S Pappo; Steven G DuBois; John T Lucas; Daphne A Haas-Kogan; Stephanie A Terezakis; Steve E Braunstein; Matthew J Krasin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-11-28       Impact factor: 7.038

2.  Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study.

Authors:  Dario Di Perri; Emmanuel Jouglar; Ellen Blanc; Anne Ducassou; Aymeri Huchet; Céline Vigneron; Alexandre Escande; Sophie Chapet; Julie Leseur; Valérie Bernier; Christian Carrie; Valentine Martin; Line Claude
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.